Canaccord Genuity Maintains a 'Hold' on Thoratec (THOR); LVAD Market Is On Fire
Tweet
Share
E-mailGet Alerts THOR Hot Sheet
Price: $26.56 +0.26%
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Hold' on Thoratec (NASDAQ: THOR) price target raised to $38.00.
Analyst, Jason R. Mills, said, "As our Q1 LVAD survey predicted (report 4/24), THOR delivered robust Q1 results that handily beat consensus projections, driven by 24% US VAD growth (14%E). OUS VAD revenue also showed upside, and implies solid OUS market growth. We expect LVAD market growth to outperform the broad med-tech space, thus recommend owning THOR & HTWR. That said, we continue to favor over-weighting HTWR, as we expect HVAD approval timing and expected Heartware (Nasdaq: HTWR) share gain will dominate the near-term “dialogue,” which may provide a better entry point in THOR shares relative to today’s expected higher open."
For an analyst ratings summary and ratings history on Thoratec click here. For more ratings news on Thoratec click here.
Shares of Thoratec closed at $34.50 yesterday.
Analyst, Jason R. Mills, said, "As our Q1 LVAD survey predicted (report 4/24), THOR delivered robust Q1 results that handily beat consensus projections, driven by 24% US VAD growth (14%E). OUS VAD revenue also showed upside, and implies solid OUS market growth. We expect LVAD market growth to outperform the broad med-tech space, thus recommend owning THOR & HTWR. That said, we continue to favor over-weighting HTWR, as we expect HVAD approval timing and expected Heartware (Nasdaq: HTWR) share gain will dominate the near-term “dialogue,” which may provide a better entry point in THOR shares relative to today’s expected higher open."
For an analyst ratings summary and ratings history on Thoratec click here. For more ratings news on Thoratec click here.
Shares of Thoratec closed at $34.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
- UBS Downgrades Converge ICT Solutions Inc (CNVRG:PM) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
